This content is machine translated Diabetes mellitus Biomarker-associated clustering for improved treatment management. Phenotyping and subclassification of diabetic patients is becoming increasingly important to provide patient-adapted treatment options. Meanwhile, there are several cluster analyses that could reveal certain specific patterns of patient characteristics.…
View Post 4 min This content is machine translated Pulmonary embolism Anticoagulate hemodynamically unstable patients even on suspicion Patients with pulmonary embolism require anticoagulation for a period of at least three months. Before starting therapy, several considerations must be addressed: Which anticoagulant is the most appropriate for this…
View Post 14 min This content is machine translated Focus on diabetes and heart New studies and new recommendations Study data in recent years have highlighted the enormous extent to which type 2 diabetes mellitus (T2D) promotes the development of cardiovascular disease. In addition, it became clear that certain…
View Post 3 min This content is machine translated Heart failure SGLT-2 inhibitors – great therapeutic potential in HFrEF patients. In addition to the SGLT-2 inhibitor dapagliflozin, which was also approved by Swissmedic last July for the treatment of heart failure (HFrEF) in non-diabetics, another member of this drug class,…
View Post 2 min This content is machine translated Heart failure Effectively reduce re-hospitalization in patients with iron deficiency Intravenous iron (III) carboxymaltose results in significantly fewer hospital readmissions in patients with heart failure and iron deficiency compared with placebo. This is the conclusion of a study published in…
View Post 3 min This content is machine translated Myocardial infarction Survived a heart attack – and now? Post-infarct management up-to date After an acute myocardial infarction, postinfarction management is the focus of treatment. To prevent another coronary event, it is essential to identify and treat appropriate risk factors. Non-drug interventions have…
View Post 1 min This content is machine translated Continuing education series on type 2 diabetes (2021) Dia-Month Club Module 4: Heart In the fourth module of the Dia-Month Club on September 3, Prof. Christian Müller (University Hospital Basel) used current data to show how modern diabetes management decisively reduces the patient’s… CME-Test
View Post 3 min This content is machine translated Cardio-renal syndrome Iron substitution: when, how and for how long? Iron deficiency in cardio-renal patients is not a trivial matter. Chronic heart failure, for example, is not only a common condition but also often associated with iron deficiency. This in…
View Post 2 min This content is machine translated Atrial fibrillation Patient safety writ large – focus on therapy For many people, the heart gets out of sync. Atrial fibrillation is one of the most common forms of cardiac arrhythmia and should be treated promptly to minimize the risk…
View Post 11 min This content is machine translated Thoracic surgery operations Prevention and treatment of respiratory and cardiac disorders. Any surgery can cause problems with the circulation, heart or lungs postoperatively. The prevention of such complications and their treatment is of great importance, because otherwise the perioperative risk increases… CME-Test
View Post 5 min This content is machine translated Type 2 diabetes mellitus SGLT-2 inhibitor has cardioprotective effect in different risk groups Type 2 diabetes mellitus (T2DM) significantly increases the risk of cardiovascular complications [1]. However, SGLT-2 inhibitors may prevent cardiovascular events in addition to lowering blood glucose levels [2, 3]. For…
